
Other members of the Management Board are Dr. Bartl Wimmer retired from this position at the end of March 2018. The former CEO and co-founder of synlab, Dr. Mathieu Floreani is the CEO of SYNLAB Group, who changed from DHL to SYNLAB in 2018. It won a tender for a centralised pathology service to serve Guy's and St Thomas' NHS Foundation Trust, King's College Hospital NHS Foundation Trust, South London and Maudsley NHS Foundation Trust, Oxleas NHS Foundation Trust and Royal Brompton and Harefield NHS Foundation Trust for 15 years in January 2020.

Regarding the areas of environment, food and hygiene diagnostics, the company offers services with regard to air, water and soil analytics as well as food and environment security among others. In diagnostics for the pharmaceutical industry, SYNLAB collaborates with other companies and universities on drug development and drug security.
#Spylab wikipedia professional
In addition, the company offers veterinary diagnostics for livestock, pets and animals competing in professional sports.

SYNLAB`s multidisciplinary range of services includes in the field of human medicine amongst others clinical chemistry, haematology, coagulation, microbiology, serology, immunology, genetics, molecular biology, pathology, cytology, endocrinology and maternity care. The company provides laboratory services to patients, physicians, hospitals and veterinary clinics as well as for the industry and for research institutions. Approximately 50 new parameters are added each year.

urine, blood, tissue, soil, drinking water) every year on the basis of around 5,000 different test parameters. The SYNLAB laboratories examine 450 million samples (e.g. The company provides diagnostics services for human and veterinary medicine as well as for environmental analysis and for the pharmaceutical industry.
